Comprehensive Study Notes on Wound Healing, Abnormal Scars, Nutritional Assessment, Sutures, and Reconstructive Z-Plasty

Wound Healing Mechanics and Tensile Strength

Timeline of Tensile Strength Gain

Following primary direct wound closure (such as a laceration closure on the forearm), the recovery of tissue tensile strength progresses through distinct timeframes:

• 1 Week Post-Closure: Scar tissue possesses approximately $3\%$ of its preinjury tensile strength.
• 3 Weeks Post-Closure: Tensile strength increases to approximately $30\%$ of preinjury levels.
• 3 Months (90 Days / 10 to 12 Weeks) Post-Closure: Tensile strength reaches approximately $80\%$ of preinjury levels.

Scar tissue never regains $100\%$ of the original uninjured skin strength. The maximum achievable tensile strength is permanently capped at roughly $80\%$.

Growth Factors in Secondary Intention Healing

Key Growth Factors and Cell Responses

Wound healing by secondary intention requires coordinated signaling among multiple growth factors to drive cell migration, matrix synthesis, and tissue remodeling:

• Transforming Growth Factor-Beta ($\text{TGF-}\beta$):   Promotes fibroblast migration and proliferation. It acts as a primary mediator of collagen synthesis and extracellular matrix deposition.
• Fibroblast Growth Factor (FGF):   Stimulates fibroblast proliferation and endothelial growth for angiogenesis (it does not decrease fibroblast activity).
• Vascular Endothelial Growth Factor (VEGF):   Secreted primarily by macrophages, epidermal cells, and keratinocytes in response to tissue injury and hypoxia to promote vascular endothelial cell migration (rather than being produced exclusively by endothelial cells).
• Epidermal Growth Factor (EGF):   Promotes keratinocyte proliferation and migration across the wound bed to re-establish mucosal and epidermal barriers.
• Platelet-Derived Growth Factor (PDGF):   Functions as a potent chemoattractant for fibroblasts and smooth muscle cells, driving cellular migration and extracellular matrix deposition.

Abnormal Scar Pathophysiology and Management

Differentiating Keloids from Hypertrophic Scars

• Growth Borders: The definitive clinical feature distinguishing a keloid from a hypertrophic scar is growth beyond the original wound borders. Keloids routinely extend into adjacent uninjured tissue, whereas hypertrophic scars remain confined strictly within the boundaries of the original wound.
• Physical Traits: Both scar types can exhibit elevation, erythema, and irregular shapes, making border expansion the crucial diagnostic discriminator.

Optimal Management of Ear Pinna Keloids

• Treatment Selection: For a mature keloid scar (such as a $1\,\text{cm}$ keloid on the ear pinna following ear piercing $12\text{ months}$ prior), standalone treatments like simple surgical excision carry high recurrence rates (often exceeding $50\text{--}80\%$).
• Combination Therapy: The optimal management strategy associated with the lowest risk of recurrence is combination therapy, which couples surgical excision with adjuvants such as intralesional corticosteroid injections, radiation, silicone sheeting, or pressure dressings.

Implant Biofilms and Host Interactions

Biofilm Characteristics and Immune Evasion

• Immune & Antibiotic Evasion: Bacterial biofilms forming around foreign implants (e.g., breast prostheses) produce an extracellular polymeric substance matrix. This protective barrier enables the biofilm to evade host immune responses and renders systemic antibiotic therapy largely ineffective.
• Diagnostic Limitations: Biofilms cannot be reliably identified using routine blood or surface wound cultures; specialized techniques like sonication or molecular testing are necessary.
• Recurrence: Incomplete removal or failure to eliminate contamination during debridement leads to rapid reformation of the biofilm on adjacent structures or replacement devices.

Preoperative Risk Assessment: Glycemic Control and Nutritional Markers

Preoperative Glycemic Control ($\text{HbA}_{1\text{c}}$)

• Surgical Site Infection Correlation: Elevated glycated hemoglobin ($\text{HbA}_{1\text{c}}$) levels linearly correlate with an increased risk of postoperative surgical site infections (SSIs) and wound healing complications.
• Diagnostic Thresholds: A normal $\text{HbA}_{1\text{c}}$ value is below $5.7\%$. Preoperative levels around $12\%$ indicate severe uncontrolled diabetes, significantly increasing postoperative complication risks.

Serum Albumin and Prealbumin Evaluation

• Predictive Value of Albumin: Serum albumin is a well-established, independent predictor of 30-day postoperative morbidity and mortality. Preoperative hypoalbuminemia correlates directly with increased rates of:

  • Surgical site infections (SSIs)
  • Wound dehiscence
  • Flap failure
  • Sepsis
  • Overall mortality

• Pharmacokinetics and Half-Lives:

  • Serum Albumin Half-Life: Approximately $20\text{ to }21\text{ days}$. Due to this extended half-life, albumin serves as a marker for baseline chronic nutritional status.
  • Prealbumin Half-Life: Approximately $2\text{ days}$. Prealbumin's short half-life makes it a sensitive indicator for acute nutritional fluctuations and short-term dietary improvements.

• Nutritional Stratification Thresholds:

  • Normal Serum Albumin: $3.5\text{ to }5.0\,\text{g/dL}$. A value of $4.3\,\text{g/dL}$ represents normal baseline nutritional status.
  • Rule of Fours for Nutritional Risk Stratification:
  • Normal: $> 4.0\,\text{g/dL}$
  • Mild Malnutrition: $3.5\text{ to }4.0\,\text{g/dL}$
  • Moderate Malnutrition: $2.5\text{ to }3.0\,\text{g/dL}$
  • Severe Malnutrition: $< 2.5\,\text{g/dL}$

Surgical Sutures and Material Selection

Absorbable Suture Characteristics

• Dexon 20 (Polyglycolic Acid): Unusual among absorbable suture materials because it is available in both monofilament and braided forms.
• Comparative Absorbable Materials:
  • Vicryl (Polyglactin 910): Braided synthetic absorbable suture.
  • Vicryl Rapide: Fast-absorbing braided synthetic suture.
  • Monocryl (Poliglecaprone 25): Monofilament synthetic absorbable suture.
  • Caprosyn: Fast-absorbing monofilament synthetic suture.

Reconstructive Surgery: Z-Plasty Principles and Techniques

Biomechanics and Flap Modifications

• Double-Opposing Semicircular Flap Modification: A specialized modification of the Z-plasty design utilized to effectively close circular surgical defects.
• Angle & Lengthening Dynamics:
  • Standard $60^\circ$ Z-plasty internal angles yield a theoretical length increase of $75\%$ along the central limb.
  • Actual clinical gain in central limb length is routinely less than theoretical predictions due to tissue tension and viscoelastic skin properties.
• Multiple vs. Single Z-Plasties: Constructing multiple smaller Z-plasties in series generates the same total theoretical lengthening as a single large Z-plasty while causing less lateral tissue distortion and achieving improved conformity to anatomical contours.